{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:18:29Z","timestamp":1787789909597,"version":"build-2784847793"},"reference-count":113,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011671","name":"G Harold and Leila Y Mathers Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001491","name":"Belgian American Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009710","name":"Myocarditis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacbts.2026.101636","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:56:47Z","timestamp":1784926607000},"page":"101636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional Autoantibodies in Myocardial Diseases"],"prefix":"10.1016","volume":"11","author":[{"given":"Simon","family":"Vanhentenrijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Silvio Nunes","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101636_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacbts.2026.101636_bib2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1500909","article-title":"Cardiac autoantibodies promote a fibrotic transcriptome and reduced ventricular recovery in human myocarditis","volume":"16","author":"Myers","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0735-1097(10)80331-6","article-title":"Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy","volume":"16","author":"Neumann","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurjhf\/hfs123","article-title":"Long-term benefits of immunoadsorption in \u03b2(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy","volume":"14","author":"Dandel","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","article-title":"Autoantibodies in heart failure and cardiac dysfunction","volume":"110","author":"Kaya","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2026.101636_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ehj.2004.05.012","article-title":"Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy","volume":"25","author":"Baba","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib8","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1253\/circj.CJ-09-0748","article-title":"Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure","volume":"74","author":"Baba","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacbts.2026.101636_bib9","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.12729","article-title":"Immunology of membranous nephropathy: from animal models to humans","volume":"183","author":"Sinico","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103755","article-title":"Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: a systematic review and meta-analysis","volume":"24","author":"Zhang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jacbts.2026.101636_bib12","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1073\/pnas.1911464116","article-title":"IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction","volume":"116","author":"Wu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2026.101636_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41590-023-01445-w","article-title":"Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course","volume":"24","author":"Muri","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","article-title":"A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators","volume":"333","author":"Mason","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heart.84.1.106","article-title":"Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy","volume":"84","author":"Elliott","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2026.101636_bib16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","article-title":"Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension","volume":"18","author":"Fu","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacbts.2026.101636_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacbts.2026.101636_bib19","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","article-title":"AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor","volume":"101","author":"Dechend","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","article-title":"Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy","volume":"347","author":"Wallukat","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tips.2020.11.013","article-title":"Autoantibodies as endogenous modulators of GPCR signaling","volume":"42","author":"Skiba","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2026.101636_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/pros.23284","article-title":"Autoantibodies directed against the endothelin A receptor in patients with benign prostatic hyperplasia","volume":"77","author":"Wallukat","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.jacbts.2026.101636_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/eht506","article-title":"High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression","volume":"35","author":"Youker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/cvr\/cvad042","article-title":"Clinical and prognostic associations of autoantibodies recognizing adrenergic\/muscarinic receptors in patients with heart failure","volume":"119","author":"Markousis-Mavrogenis","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101636_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41569-019-0220-3","article-title":"G protein-coupled receptor kinases as therapeutic targets in the heart","volume":"16","author":"Pfleger","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fj.04-3001com","article-title":"Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship","volume":"20","author":"Warraich","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2026.101636_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0735-1097(00)00881-0","article-title":"Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies","volume":"36","author":"Jahns","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.RES.88.6.578","article-title":"Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo","volume":"88","author":"Iwata","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2026.101636_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCULATIONAHA.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/eurjhf\/hfs118","article-title":"Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-\u03b21-adrenergic receptor antibody neutralization and of immune parameters","volume":"14","author":"M\u00fcnch","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1067\/mhj.2002.124406","article-title":"Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates","volume":"143","author":"Warraich","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2016.03.005","article-title":"Autoantibodies specifically against \u03b21 adrenergic receptors and adverse clinical outcome in patients with chronic systolic heart failure in the \u03b2-blocker era: the importance of immunoglobulin G3 subclass","volume":"22","author":"Nagatomo","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jacc.2016.11.067","article-title":"Myocardial recovery in patients with systolic heart failure and autoantibodies against \u03b2(1)-adrenergic receptors","volume":"69","author":"Nagatomo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1091\/mbc.E20-06-0394","article-title":"The IgG3 subclass of \u03b21-adrenergic receptor autoantibodies is an endogenous biaser of \u03b21AR signaling","volume":"32","author":"Mohan","year":"2021","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jacbts.2026.101636_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-007-0686-8","article-title":"Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications","volume":"103","author":"Lazzerini","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/s12872-021-02414-7","article-title":"Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacbts.2026.101636_bib38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2009.07.015","article-title":"Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism","volume":"54","author":"Stavrakis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib39","article-title":"The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2026.101636_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jjcc.2019.02.013","article-title":"Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: a 5-year prospective study","volume":"74","author":"Ma","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib41","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/diagnostics11112165","article-title":"Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: frequency, clinical and prognostic correlates","volume":"11","author":"Caforio","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jacbts.2026.101636_bib42","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.85.5.1734","article-title":"Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy","volume":"85","author":"Caforio","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib43","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3390\/jcm10112476","article-title":"Serum anti-heart and anti-intercalated disk autoantibodies: novel autoimmune markers in cardiac sarcoidosis","volume":"10","author":"Caforio","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib44","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11596-010-0546-x","article-title":"Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction","volume":"30","author":"Liu","year":"2010","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.jacbts.2026.101636_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacbts.2016.12.001","article-title":"Cardiac myosin binding protein-C autoantibodies are potential early indicators of cardiac dysfunction and patient outcome in acute coronary syndrome","volume":"2","author":"Lynch","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101636_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009052","article-title":"Immune-mediated myocarditis in Fabry disease cardiomyopathy","volume":"7","author":"Frustaci","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2026.101636_bib47","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.118.036068","article-title":"Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus","volume":"139","author":"Sousa","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.119.044539","article-title":"Cardiac autoimmunity is associated with subclinical myocardial dysfunction in patients with type 1 diabetes mellitus","volume":"141","author":"Sousa","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib49","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1074\/jbc.M808615200","article-title":"Structure and orientation of troponin in the thin filament","volume":"284","author":"Paul","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacbts.2026.101636_bib50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib51","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","article-title":"Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice","volume":"9","author":"Okazaki","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2026.101636_bib53","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.106.635664","article-title":"Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium","volume":"114","author":"G\u00f6ser","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010347","article-title":"Cardiac autoantibodies against cardiac troponin I in post-myocardial infarction heart failure: evaluation in a novel murine model and applications in therapeutics","volume":"16","author":"Furusawa","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib55","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehn268","article-title":"Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction","volume":"29","author":"Leuschner","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib56","first-page":"41","article-title":"Autoantibodies against cardiac troponin I in patients presenting with myocarditis","volume":"6","author":"Matsumori","year":"2011","journal-title":"CVD Prev Control"},{"key":"10.1016\/j.jacbts.2026.101636_bib57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehaf975","article-title":"Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study","volume":"47","author":"Teppo","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.035128","article-title":"Role of antitroponin antibodies and macrotroponin in the clinical interpretation of cardiac troponin","volume":"13","author":"Salaun","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2026.101636_bib59","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1373\/clinchem.2009.125781","article-title":"Prevalence of autoantibodies to cardiac troponin T in healthy blood donors","volume":"55","author":"Adamczyk","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacbts.2026.101636_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib61","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1111\/j.1582-4934.2008.00438.x","article-title":"Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations","volume":"13","author":"Fidler","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1540-8167.1998.tb00942.x","article-title":"Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation","volume":"9","author":"Maixent","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000149152","article-title":"Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo","volume":"112","author":"Hong","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacbts.2026.101636_bib65","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/01.CIR.0000136825.96029.A5","article-title":"Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation","volume":"110","author":"Mandal","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1479-5876-11-49","article-title":"Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation","volume":"11","author":"Kornej","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCULATIONAHA.122.062776","article-title":"Autoimmune atrial fibrillation","volume":"148","author":"Maguy","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0b013e31816c4325","article-title":"Inward rectifier potassium currents as a target for atrial fibrillation therapy","volume":"52","author":"Ehrlich","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101636_bib69","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jacbts.2026.101636_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cvr\/cvt021","article-title":"L-type calcium channel targeting and local signalling in cardiac myocytes","volume":"98","author":"Shaw","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101636_bib72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3083.2010.02428.x","article-title":"Anti-Ro\/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses","volume":"72","author":"Lazzerini","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib73","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1093\/eurheartj\/ehac348","article-title":"Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial","volume":"43","author":"Chimenti","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib74","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacc.2013.04.041","article-title":"Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats","volume":"62","author":"Korkmaz","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib75","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","article-title":"Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives","volume":"115","author":"Caforio","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib77","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1038\/s41598-023-32081-x","article-title":"Evaluation of autoantibodies to desmoglein-2 in dogs with and without cardiac disease","volume":"13","author":"Walker","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101636_bib78","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","article-title":"Evidence from family studies for autoimmunity in arrhythmogenic right ventricular cardiomyopathy: associations of circulating anti-heart and anti-intercalated disk autoantibodies with disease severity and family history","volume":"141","author":"Caforio","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib79","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.3390\/jcm13226736","article-title":"Prevalence and correlates of anti-DSG2 antibodies in arrhythmogenic right ventricular cardiomyopathy and myocarditis: immunological insights from a multicenter study","volume":"13","author":"Giordani","year":"2024","journal-title":"J Clin Med"},{"issue":"Suppl_1","key":"10.1016\/j.jacbts.2026.101636_bib80","article-title":"Clinical value of anti-DSG2 antibodies in arrhythmogenic right ventricular cardiomyopathy: a real-life experience","volume":"45","author":"Borowiec","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1083\/jcb.119.1.179","article-title":"Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies","volume":"119","author":"Meyer","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jacbts.2026.101636_bib82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00018-023-04853-1","article-title":"Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesion","volume":"80","author":"Yeruva","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacbts.2026.101636_bib83","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.115.009800","article-title":"Pathogenesis of the novel autoimmune-associated long-QT syndrome","volume":"132","author":"Yue","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib84","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20040358","article-title":"Molecular characterization of virus-induced autoantibody responses","volume":"200","author":"Ludewig","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaut.2007.01.003","article-title":"Molecular mapping of autoimmune B cell responses in experimental myocarditis","volume":"28","author":"Krebs","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jacbts.2026.101636_bib86","first-page":"1055","article-title":"PhIP-Seq reveals autoantibodies for ubiquitously expressed antigens in viral myocarditis","volume":"11","author":"Rasquinha","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jacbts.2026.101636_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/circ.146.suppl_1.15752","article-title":"Abstract 15752: differential IgG repertoire in individuals with Chagas cardiomyopathy","volume":"146","author":"Venturini","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib88","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMc2205667","article-title":"IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination","volume":"387","author":"Thurner","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101636_bib89","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14291","article-title":"Evaluation of autoantibody binding to cardiac tissue in multisystem inflammatory syndrome in children and COVID-19 vaccination\u2013induced myocarditis","volume":"6","author":"Patel","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacbts.2026.101636_bib90","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post\u2013COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib91","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2013.05.001","article-title":"Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance","volume":"43","author":"Mavrogeni","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jacbts.2026.101636_bib92","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101636_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jacbts.2026.101636_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/ar3752","article-title":"Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study","volume":"14","author":"Giles","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jacbts.2026.101636_bib95","article-title":"Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: a common trigger for different microvascular diseases","volume":"9","author":"Moschetti","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jacbts.2026.101636_bib96","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1097\/RHU.0000000000001777","article-title":"Autoantibodies in patients with immune-related adverse events from checkpoint inhibitors: a systematic literature review","volume":"28","author":"Ghosh","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jacbts.2026.101636_bib97","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nbt.1856","article-title":"Autoantigen discovery with a synthetic human peptidome","volume":"29","author":"Larman","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2026.101636_bib98","article-title":"High-throughput identification of autoantibodies that target the human exoproteome","volume":"2","author":"Wang","year":"2022","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.jacbts.2026.101636_bib99","article-title":"Contrastive learning enables epitope overlap predictions for targeted antibody discovery","volume":"7","author":"Holt","year":"2025","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.jacbts.2026.101636_bib100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ejhf.2496","article-title":"Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies","volume":"24","author":"Baritussio","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib101","article-title":"Serum anti-heart and antinuclear autoantibodies are independent predictors of response to immunosuppressive therapy in autoimmune biopsy-proven inflammatory cardiomyopathy","volume":"10","author":"Giordani","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101636_bib102","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jca.20137","article-title":"Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques","volume":"22","author":"Burgstaler","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jacbts.2026.101636_bib103","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jca.21446","article-title":"Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety","volume":"31","author":"Yoshikawa","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jacbts.2026.101636_bib104","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/ejhf.3476","article-title":"Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with dilated CardioMyopathy (IASO-DCM): rationale and design","volume":"26","author":"D\u00f6rr","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jca.20130","article-title":"A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy","volume":"22","author":"Cooper","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jacbts.2026.101636_bib106","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","article-title":"Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101636_bib107","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-8411(03)00042-8","article-title":"Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy","volume":"20","author":"Mobini","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jacbts.2026.101636_bib108","doi-asserted-by":"crossref","first-page":"712.e1-e6","DOI":"10.1016\/j.ahj.2006.06.027","article-title":"Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study","volume":"152","author":"Staudt","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2026.101636_bib109","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ejhf.2082","article-title":"Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial","volume":"23","author":"Hazebroek","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ejhf.2110","article-title":"Failure of intravenous immunoglobulin to improve cardiac function in parvovirus B19-associated chronic dilated cardiomyopathy","volume":"23","author":"Lyle","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101636_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108804","article-title":"Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice","volume":"114","author":"Ma","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacbts.2026.101636_bib112","article-title":"Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series","volume":"3","author":"Tsch\u00f6pe","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jacbts.2026.101636_bib113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ejhf.3467","article-title":"Add-on rituximab for primary heart involvement associated with systemic sclerosis: a step forward in the tailored treatment of myocarditis?","volume":"27","author":"De Santis","year":"2024","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:30:23Z","timestamp":1787787023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":113,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2452302X26001567"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101636","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Autoantibodies in Myocardial Diseases","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101636"}}